PKC theta inhibitor (HotSpot)

N/A

Report date: 2025/03/20 09:23:09
NME

Base Information

Drug NamePKC theta inhibitor (HotSpot)
Drug Alias Nameprotein kinase C theta inhibitor (HotSpot)allosteric inhibitors of PKC theta (HotSpot)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C theta inhibitors
TargetsProtein kinase C theta
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHotSpot Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHotSpot Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A